APPLICATIONS PUBLISHED 12 JUNE 2002

Published: 1-Dec-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Enzyme inhibitors
    Procter & Gamble 1212034*

  • Compsn for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
    Unimed Pharmaceutials 1212039*

  • Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
    Pharmacia Italia 1212040*

  • Compsn to be administered through the mucous membrane
    Capsulis 1212043*

  • Method for coating pharmaceutical dosage forms
    Boehringer Ingelheim Pharmaceuticals 1212044*

  • A vaccine compsn and method of using same
    Teva Pharmaceutical Industries 1212045*

  • Use of charged dextran as a mucoactive agent and methods and pharmaceutical compsns relating thereto
    The Governers of the University of Alberta 1212047*

  • Use of sigma receptor agonists for the treatment of depression
    Warner-Lambert 1212048*

  • Use of thiamphenicol for the treatment of Chlamydia pneumoniae infections
    Zambon Group 1212049*

  • Formulations containing tetracyclines for treating or preventing mucositis
    Orapharma 1212050*

  • Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome
    Merck 1212051*

  • Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
    Tepha 1212052*

  • Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide monohydrate
    Nitromed 1212053*

  • Azetidine compounds in CNS and eye diseases
    Vernalis Research 1212054*

  • Neurotherapeutic compsn and method
    Revaax Pharmaceuticals 1212055*

  • Methods and compsns for bisubstrate inhibitors of acetyltransferases
    The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1212056*

  • Extended duration light activated cancer therapy
    Light Sciences Corp 1212057*

  • Topical treatment for prevention of ocular infections
    Insite Vision 1212058*

  • Iron chelators and uses thereof
    University of Queensland; The Heart Research Institute 1212059*

  • Use of nicotine or derivatives thereof in a medicine for treating neurological diseases, particularly Parkinson's disease
    Assistance Publique, Hopitaux de Paris 1212060*

  • Injectable buprenorphine microparticle compsns and their use in reducing consumption of heroin and alcohol
    Southern Research Institute 1212061*

  • Use of thienopyrimidines
    Merck Patent 1212062*

  • Topical azathioprine for the treatment of oral autoimmune diseases
    Oral Solutions 1212063*

  • Use of inhibitors of endotoxin for the treatment of heart failure and cachexia
    Max-Delbrueck-Centrum fuer Molekulare Medizin 1212064*

  • Compsns and methods for raising HDL cholesterol levels
    Tularik 1212065*

  • Pro-gut maturation and anti-inflammatory effects of Lactobacillus and Lactobacillus secreted proteins, carbohydrates and lipids
    University of Maryland 1212066*

  • Use of diterpenoid triepoxides as an anti-proliferative agent
    The Board of Trustees of the Leland Stanford Junior University 1212067*

  • Method of enhancing the efficacy of anti-tumour agents
    Health Research 1212068*

    Improved topical compsns containing probiotic bacteria, spores, and extracellular products and uses thereof
    Ganeden Biotech 1212069*

  • Plant extract mixtures and their uses
    Medex Scientific 1212070*

  • Stable carotene-xanthophyll beadlet compsns and methods of use
    Alcon 1212071*

  • Pharmaceutical compsn that contains eucalyptus and orange oil
    AKH Arzneimittelkontor 1212072*

  • Method for measuring coagulant factor activity in whole blood
    The Scripps Research Institute 1212073*

  • Hybrid peptides modulate the immune response
    Antigen Express 1212074*

  • You may also like